Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
BIVI

BIOVIE (BIVI) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $1.39 +8.6% on the day -28.7% over 12 months 52-week range $0.96 – $2.28

Share price and insider trades

BIVI closeInsider buyInsider sale
0.501.001.502.002.50NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $17,481 on 2026-08-28 · Amy Suzon Chappell, Joanne Wendy Kim, Joseph M PalumboBought $31,637 on 2026-08-27 · Cuong V Do
Bought, 12 months$42K
Sold, 12 months$0
Insiders buying2
Insiders selling0

BIOVIE insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $42K and 0 sold $0 of BIVI stock on the open market.

BIVI insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $49K bought (4 trades)$49KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$49K4—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$12.1MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.0×Last 5 sessions
Insiders' paper profit−$17KOn all tracked purchases -34.1%

Summary

Over the past 12 months, 2 BIOVIE INC. insiders reported open-market purchases totaling $42K, while 0 insiders reported sales totaling $0.

BIVI stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 28SEC Cuong V DoCEO, President Buy 15,21016,117 held (+1677%) $2.08 $32K -33.2% —
Aug 28SEC Joseph M PalumboChief Medical Officer Buy 4,8436,036 held (+406%) $2.16 $10K -35.6% —
Aug 28SEC Joanne Wendy KimCFO Buy 2,5003,441 held (+266%) $2.18 $5K -36.2% —
Aug 28SEC Amy Suzon ChappellDirector Buy 727new position $2.16 $2K -35.6% —

Insiders at BIOVIE INC.

InsiderBoughtSoldLast filingScore
Cuong V DoCEO, President $32K — Aug 28, 2026 —
Joseph M PalumboChief Medical Officer $10K — Aug 28, 2026 —
Joanne Wendy KimCFO $5K — Aug 28, 2026 —
Amy Suzon ChappellDirector $2K — Aug 28, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

BIVI stock: common questions

Are BIOVIE INC. insiders buying BIVI stock?

In the past 12 months, 2 insiders reported open-market purchases of BIVI worth $42K. The latest was CEO, President Cuong V Do bought $32K of BIVI at $2.08 — first open-market purchase in our records; raises the stake by 1677%.

Are BIOVIE INC. insiders selling BIVI stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is BIVI's 52-week range?

Over the past year BIVI has traded between $0.96 and $2.28. It last closed at $1.39 on Oct 9, 2026.